Phase II trial of ArtemiCoffee for men with biochemical recurrence of prostate cancer after local therapy.

Read article at: https://ascopubs.org/doi/10.1200/JCO.2024.42.4_suppl.TPS350

Previous
Previous

Plant-Based Coffee Shows Promise in Ovarian Cancer Trial